Mary Ludlam PhD

Founder & CEO

  • Mary
  • Established biopharma R&D group leader

  • Serial drug discovery technology innovator

  • Expertise in cell biology, high-throughput microscopy and computational analysis

  • Critical role in multiple oncology programs including block-buster FDA-approved medicines

Duncan Parsons-Karavassilis PhD

VP Finance

& Operations

  • Duncan
  • Experienced strategic change manager

  • Complex system development across multiple domains

  • Start-up product development management

  • Investment banking project management and new business implementation

Susana Abreu Ribeiro PhD

Associate Director

Paris Site Head

  • Susana
  • Development of state of the art technologies for complex cell biology

  • Expert in cell line engineering, live-cell microscopy and high-throughput CRISPR screening

  • Design and implementation of tools and technologies to profile multiple oncology pathways

Catherine Lacayo PhD

Associate Director

Platform Biology

  • Susana
  • Expert in probing dynamics & perturbations in diverse cell-based formats

  • Highly skilled in cell line engineering and quantitative live-cell microscopy

  • Broad assay development skillset encompassing mammalian & iPS cells applied to toxicity testing & disease modeling

Salomé Botelho

Scientist

Amin Fehri

Data Scientist

David Wartmann

Associate Engineer

Annie Truong

Research Associate

Oliver Lai

Research Associate

Vee Senires Garcillano

Administration & Laboratory Management

  • Susana